Etretinate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for etretinate and what is the scope of freedom to operate?
Etretinate
is the generic ingredient in one branded drug marketed by Roche and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for etretinate
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 71 |
Clinical Trials: | 3 |
Patent Applications: | 5,706 |
DailyMed Link: | etretinate at DailyMed |
Recent Clinical Trials for etretinate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Federal University of São Paulo | Phase 4 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
M.D. Anderson Cancer Center | Phase 2 |
Medical Subject Heading (MeSH) Categories for etretinate
Anatomical Therapeutic Chemical (ATC) Classes for etretinate
US Patents and Regulatory Information for etretinate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche | TEGISON | etretinate | CAPSULE;ORAL | 019369-002 | Sep 30, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Roche | TEGISON | etretinate | CAPSULE;ORAL | 019369-001 | Sep 30, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for etretinate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Roche | TEGISON | etretinate | CAPSULE;ORAL | 019369-001 | Sep 30, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Roche | TEGISON | etretinate | CAPSULE;ORAL | 019369-002 | Sep 30, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Roche | TEGISON | etretinate | CAPSULE;ORAL | 019369-002 | Sep 30, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Roche | TEGISON | etretinate | CAPSULE;ORAL | 019369-001 | Sep 30, 1986 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |